Innoviva, Inc.
Innoviva is a biopharmaceutical company that develops and commercializes respiratory products.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Innoviva's stock with a target price of $36.20, indicating significant growth potential.
Financial Health
Innoviva is performing well with strong revenue, cash flow, and profit margins, indicating solid financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring INVA
Pharma's Pricing Pressure
In response to a presidential ultimatum for 17 drug makers to slash U.S. prices, the pharmaceutical industry faces a major regulatory challenge. This event creates a potential investment opportunity in companies positioned to gain from the pricing disruption, including generic manufacturers.
Published: August 3, 2025
Explore BasketIntellectual Property
These companies own valuable ideas, brands, and inventions that generate reliable, contract-guaranteed income. Their asset-light business models create high-margin revenue streams without the costs of physical production, making them potential profit powerhouses across multiple industries.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Royalty Income Model
Innoviva earns from product sales via royalties, which can deliver steady cash when partners perform — though revenues depend on third-party sales and can vary.
Market Exposure
Concentration in respiratory and speciality medicines links returns to a specific healthcare segment; regulatory or competitive shifts can materially affect outcomes.
Balance Sheet Focus
Investors often watch cash, dividend policy and capital allocation; strong financials can cushion volatility, but no outcome is guaranteed.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
